NCT07334951

Brief Summary

Avoid unhealthy foods, walk every day for at least 15 min , sleep well, he should take sessions at its time, family should Avoid disturbances, keep quiet as much as possible, make Analysis recoired before and after interaction.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jan 2026Aug 2026

First Submitted

Initial submission to the registry

November 30, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

January 11, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2026

Last Updated

January 13, 2026

Status Verified

September 1, 2025

Enrollment Period

7 months

First QC Date

November 30, 2025

Last Update Submit

January 12, 2026

Conditions

Keywords

Protection from diabetes in obesity

Outcome Measures

Primary Outcomes (1)

  • Glucose tolerance.

    Change in glucose tolerance assessed using 2\_hours oral glucose tolerance test (OGTT), expressed as glucose plasma area under curve (AUC), following a75 g oral glucose load.

    Baseline and after 12th weeks of intervention.

Secondary Outcomes (2)

  • Insulin resistance.

    Baseline and after 12th weeks of intervention.

  • Insulin sensitvity.

    Baseline and after 12th weeks of intervention.

Other Outcomes (6)

  • Body mass index

    Baseline and after 12 weeks of intervention.

  • Waist circumference.

    Baseline and 12 weeks after the intervention.

  • Body fat percentage.

    Baseline and after 12 weeks of intervention.

  • +3 more other outcomes

Study Arms (2)

Effect of tvns in glucose tolerance ,insulin resistance,stress hormones ,and mood states in obesity

ACTIVE COMPARATOR

All patients received transcutaneous electrical nerve stimulation. Allsubsequent ttt will be 3 times per week for 12weeks . Patients will also instructed to complete diary booklet each day to describe side effects corresponding with or temporally related to ttt. The investigators checked all booklets at the 6 and 12 week assessments. The points for tvns are located in the auricular concha area where there is rich vagus nerve branch distribution. Stimulation parameters will be 1MA of electrical current frequency of 20 HZ with pulse duration less than or equal 1ms ,administration once daily lasted 45 min the intensity adjusted based on the individual tolerance of patients. Control group Sham tavns ttt location at the superior scapha , where no vagus nerve distribution, after final session, all baseline measurements will be repeated using the same procedures . All data will be anonymized and stored securely .data will be verified by double \_checked , and analysis by SPSS v26.

Device: Trans vagus nerve stimulation electrical device.

Control group

SHAM COMPARATOR

Sham TVNS 45 min for 3 months with dietary advices .

Device: Trans vagus nerve stimulation electrical device.

Interventions

Tvns located at auricular concha area For 45min three times per week for 3 months.

Also known as: TVNS electrical device .
Control groupEffect of tvns in glucose tolerance ,insulin resistance,stress hormones ,and mood states in obesity

Eligibility Criteria

Age40 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta general hospital

Tanta, Algarbia, 31511, Egypt

Location

Related Publications (1)

  • Barazzoni R metal 2023 ,aerobic training

    RESULT

MeSH Terms

Conditions

ObesityDiabetes Mellitus

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Sham tVNS for 45 min 3 times per week in addition to dietary advices for 3 months .
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: They will receive TVNS for 45 min , 3times per week inaddition to dietary advices for months.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Effect of auricular vagus nerve stimulation on glucose tolerance, and mood states in obesity

Study Record Dates

First Submitted

November 30, 2025

First Posted

January 12, 2026

Study Start

January 11, 2026

Primary Completion (Estimated)

August 21, 2026

Study Completion (Estimated)

August 21, 2026

Last Updated

January 13, 2026

Record last verified: 2025-09

Locations